Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: A clue to the diagnosis

American Journal of Surgical Pathology

Volumn 35, Issue 7, 2011, Pages 981-988

  Meriden, Zina ^a   Shi, Chanjuan ^a   Edil, Barish H ^b   Ellison, Trevor ^b   Wolfgang, Christopher L ^b   Cornish, Toby C ^a   Schulick, Richard D ^b   Hruban, Ralph H ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

hyaline globules; islet cell tumor; pancreas; pancreatic neuroendocrine tumor; solid pseudopapillary tumor

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; HYALIN; MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ARTICLE; CARCINOMA; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; PERIODIC ACID SCHIFF STAIN;

BETA CATENIN; CARCINOMA, NEUROENDOCRINE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; HYALIN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPRILYSIN; PANCREATIC NEOPLASMS; PERIODIC ACID-SCHIFF REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79959635340     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31821a9a14     Document Type: Article

References (59)

1. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160:1361-1369. (Pubitemid 34411640)
2. Bhanot P, Nealon WH, Walser EM, et al. Clinical, imaging, and cytopathological features of solid pseudopapillary tumor of the pancreas: a clinicopathologic study of three cases and review of the literature. Diagn Cytopathol. 2005;33:421-428. (Pubitemid 41780466)
3. Bosman F, Carneiro F, Hruban R, et al. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010.
4. Contessa JN, Griffith KA, Wolff E, et al. Radiotherapy for pancreatic neuroendocrine tumors. Int J Radiat Oncol Biol Phys. 2009;75:1196-1200.
5. Deshpande V, Fernandez-del CC, Muzikansky A, et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004;28:1145-1153. (Pubitemid 39121608)
6. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
7. Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798-7803.
8. Fazio N, Cinieri S, Lorizzo K, et al. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas. Cancer Treat Rev. 2010;36(Suppl 3):S87-S94.
9. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 2008;95:627-635.
10. Garg SK, Vashist R, Pathak IC, et al. Ectopic ACTH syndrome due to islet cell carcinoma in a 12 year old child. Indian J Pediatr. 1988; 55:155-160.
11. Goh BK, Tan YM, Cheow PC, et al. Solid pseudopapillary neoplasms of the pancreas: an updated experience. J Surg Oncol. 2007;95:640-644. (Pubitemid 46954809)
12. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642. (Pubitemid 34575635)
13. Horsch D, Tielke S, Schrader J. Expression and activation of mTOR in neuroendocrine tumors. Effects of mTOR inhibition by RAD001 upon growth, cell cycle regulation and signalling in neuroendocrine cell lines. J Clin Oncol. 2007;25:10570.
14. Iacono C, Serio G, Fugazzola C, et al. Cystic islet cell tumors of the pancreas: a clinico-pathological report of two nonfunctioning cases and review of the literature. Int J Pancreatol. 1992;11: 199-208.
15. Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1 and mTOR Pathway Genes are Frequently Altered in Pancreatic Neuroendocrine Tumors. Science Express. 2011;331:1199-1203.
16. Kaufman SL, Reddick RL, Stiegel M, et al. Papillary cystic neoplasm of the pancreas: a curable pancreatic tumor. World J Surg. 1986;10:851-859. (Pubitemid 17197540)
17. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol. 2007;20(Suppl 1):S94-112.
18. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17:66-80. (Pubitemid 30132100)
19. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996;429:323-333. (Pubitemid 26421392)
20. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40:30-40.
21. Ladanyi M, Mulay S, Arseneau J, et al. Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations. Cancer. 1987;60:1604-1611. (Pubitemid 17141015)
22. Lai HW, Su CH, Li AF, et al. Malignant solid and pseudopapillary tumor of the pancreas: clinicohistological, immunohistochemical, and flow cytometric evaluation. Hepatogastroenterology. 2006;53: 291-295.
23. Lam KY, Lo CY, Fan ST. Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg. 1999;23:1045-1050. (Pubitemid 29451723)
24. Lee SE, Jang JY, Lee KU, et al. Clinical comparison of distal pancreatectomy with or without splenectomy. J Korean Med Sci. 2008;23:1011-1014.
25. Lieber MR, Lack EE, Roberts JR Jr, et al. Solid and papillary epithelial neoplasm of the pancreas: an ultrastructural and immunocytochemical study of six cases. Am J Surg Pathol. 1987; 11:85-93. (Pubitemid 17004961)
26. Lillemoe KD, Kaushal S, Cameron JL, et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg. 1999;229: 693-698.
27. Liu X, Rauch TM, Siegal GP, et al. Solid-pseudopapillary neoplasm of the pancreas: three cases with a literature review. Appl Immunohistochem Mol Morphol. 2006;14:445-453. (Pubitemid 44813707)
28. Liu BA, Li ZM, Su ZS, et al. Pathological differential diagnosis of solid-pseudopapillary neoplasm and endocrine tumors of the pancreas. World J Gastroenterol. 2010;16:1025-1030.
29. Martin RC, Klimstra DS, Brennan MF, et al Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol. 2002; 9:35-40. (Pubitemid 34262895)
30. Menegaux F, Schmitt G, Mercadier M, et al. Pancreatic insulinomas. Am J Surg. 1993;165:243-248. (Pubitemid 23281375)
31. Miettinen M, Partanen S, Fraki O, et al. Papillary cystic tumor of the pancreas: an analysis of cellular differentiation by electron microscopy and immunohistochemistry. Am J Surg Pathol. 1987; 11:855-865. (Pubitemid 18003395)
32. Missiaglia E, Dalai I, Barbi S, et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2010;28:245-255.
33. Nishimori I, Kohsaki T, Tochika N, et al. Non-cystic solidpseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of beta-catenin. Pathol Int. 2006;56:707-711. (Pubitemid 44570023)
34. Notohara K, Hamazaki S, Tsukayama C, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol. 2000; 24:1361-1371.
35. Notohara K, Wani Y, Fujisawa M. Solid pseudopapillary neoplasm: pathological diagnosis and distinction from other solid cellular tumours of the pancreas. Diagnostic Histopathology. 2008;14: 266-274. (Pubitemid 351932175)
36. Paner GP, Thompson KS, Reyes CV. Hepatoid carcinoma of the pancreas. Cancer. 2000;88:1582-1589. (Pubitemid 30183143)
37. Papavramidis T, Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005;200:965-972. (Pubitemid 40744806)
38. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113:256-265.
39. Pasquiou C, Scoazec JY, Gentil-Perret A, et al. Solid pseudopapillary tumors of the pancreas. Pathology report of 13 cases. Gastroenterol Clin Biol. 1999;23:207-214. (Pubitemid 29217293)
40. Pettinato G, Manivel JC, Ravetto C, et al. Papillary cystic tumor of the pancreas. A clinicopathologic study of 20 cases with cytologic, immunohistochemical, ultrastructural, and flow cytometric observations, and a review of the literature. Am J Clin Pathol. 1992;98:478-488.
41. Phan GQ, Yeo CJ, Cameron JL, et al. Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: fifty patients. Surgery. 1997;122:989-996.
42. Ray S, Lu Z, Rajendiran S. Clear cell ductal adenocarcinoma of pancreas: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:693-696. (Pubitemid 41490434)
43. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401. (Pubitemid 44451313)
44. Salla C, Chatzipantelis P, Konstantinou P, et al. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a case report and literature review. World J Gastroenterol. 2007;13:5158-5163. (Pubitemid 47527357)
45. Schmitt AM, Anlauf M, Rousson V, et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol. 2007;31:1677-1682. (Pubitemid 350287565)
46. Stommer P, Kraus J, Stolte M, et al. Solid and cystic pancreatic tumors: clinical, histochemical, and electron microscopic features in ten cases. Cancer. 1991;67:1635-1641.
47. Strosberg J, Hoffe S, Gardner N, et al. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy. Neuroendocrinology. 2007;85:216-220. (Pubitemid 47123456)
48. Tajiri T, Inagaki T, Ohike N, et al. Intraductal oncocytic papillary carcinoma of the pancreas showing numerous hyaline globules in the lumen. Pathol Int. 2010;60:48-54.
49. Tanaka Y, Notohara K, Kato K, et al. Usefulness of betacatenin immunostaining for the differential diagnosis of solidpseudopapillary neoplasm of the pancreas. Am J Surg Pathol. 2002;26:818-820. (Pubitemid 34546954)
50. Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol. 2005;29:512-519. (Pubitemid 40411185)
51. Tennvall J, Ljungberg O, Ahren B, et al. Radiotherapy for unresectable endocrine pancreatic carcinomas. Eur J Surg Oncol. 1992;18:73-76.
52. Tipton SG, Smyrk TC, Sarr MG, et al. Malignant potential of solid pseudopapillary neoplasm of the pancreas. Br J Surg. 2006;93: 733-737. (Pubitemid 43886027)
53. Torrisi JR, Treat J, Zeman R, et al. Radiotherapy in the management of pancreatic islet cell tumors. Cancer. 1987;60:1226-1231. (Pubitemid 17152898)
54. Udelsman R, Yeo CJ, Hruban RH, et al. Pancreaticoduodenectomy for selected pancreatic endocrine tumors. Surg Gynecol Obstet. 1993;177:269-278. (Pubitemid 23262675)
55. Venkatesh S, Ordonez NG, Ajani J, et al. Islet cell carcinoma of the pancreas: a study of 98 patients. Cancer. 1990;65:354-357. (Pubitemid 20035366)
56. Yao JC, Shah MH, Ito T, et al. A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET) (RADIANT-3). Ann Oncol. 2010;21.
57. Yeo CJ. Neoplasms of the endocrine pancreas. In: Greenfield LJ, Mulholland MW, Oldham KT, eds. Surgery: Scientific Principles and Practice. Philadelphia, PA: Lippincott; 2001:899-913.
58. Zhang H, Liang TB, Wang WL, et al. Diagnosis and treatment of solid-pseudopapillary tumor of the pancreas. Hepatobilliary Pancreat Dis Int. 2006;5:454-458. (Pubitemid 44295205)
59. Zitzmann K, De Toni EN, Brand S, et al. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology. 2007;85:54-60. (Pubitemid 46550026)